Evidence map›Paper›PMID 35472164›Full record

ArticleBlood2022

Procoagulant platelet sentinels prevent inflammatory bleeding through GPIIBIIIA and GPVI.

Rainer Kaiser, Raphael Escaig, Jan Kranich, Marie-Louise Hoffknecht, Afra Anjum, Vivien Polewka, Magdalena Mader, Wenbo Hu, Larissa Belz, Christoph Gold and 9 more

Open access · greenAbstract read
In one paragraph

Article in Blood, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 32 papers.

0numbers the graph read from it
0cells of the map it votes in
32citing papers in PubMed
11.5field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

32 citing papers in PubMed, 75 citations in OpenAlex.

  1. Article
  2. Article
  3. Mechanisms of Piezo1-Mediated Mechanotransduction in Thrombotic Diseases.International journal of molecular sciences · 2026
    Review
  4. Article
  5. Review
  6. Article
  7. Platelet mTOR Is a Regulator of Sterile Immunothrombosis.Arteriosclerosis, thrombosis, and vascular biology · 2026
    Article
  8. Platelet effector functions in inflammation.Research and practice in thrombosis and haemostasis · 2026
    Review
  9. Article
  10. Article
  11. Observational
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Biomedical application of TiOCell biology and toxicology · 2024
    Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

19 authors at 2 institutions in 1 country.

Rainer KaiserMedizinische Klinik und Poliklinik I, University Hospital, Ludwig-Maximilian University, Munich, Germany.ORCID 0000-0003-1750-3395
Raphael EscaigMedizinische Klinik und Poliklinik I, University Hospital, Ludwig-Maximilian University, Munich, Germany.
Jan KranichInstitute for Immunology, Biomedical Center, Medical Faculty, Ludwig-Maximilian University, Munich, Planegg-Martinsried, Germany.ORCID 0000-0002-9928-4132
Marie-Louise HoffknechtMedizinische Klinik und Poliklinik I, University Hospital, Ludwig-Maximilian University, Munich, Germany.ORCID 0000-0002-5894-0308
Afra AnjumMedizinische Klinik und Poliklinik I, University Hospital, Ludwig-Maximilian University, Munich, Germany.ORCID 0000-0002-1976-4102
Vivien PolewkaMedizinische Klinik und Poliklinik I, University Hospital, Ludwig-Maximilian University, Munich, Germany.
Magdalena MaderMedizinische Klinik und Poliklinik I, University Hospital, Ludwig-Maximilian University, Munich, Germany.
Wenbo HuInstitute for Immunology, Biomedical Center, Medical Faculty, Ludwig-Maximilian University, Munich, Planegg-Martinsried, Germany.
Larissa BelzMedizinische Klinik und Poliklinik I, University Hospital, Ludwig-Maximilian University, Munich, Germany.
Christoph GoldMedizinische Klinik und Poliklinik I, University Hospital, Ludwig-Maximilian University, Munich, Germany.
Anna TitovaMedizinische Klinik und Poliklinik I, University Hospital, Ludwig-Maximilian University, Munich, Germany.
Michael LorenzMedizinische Klinik und Poliklinik I, University Hospital, Ludwig-Maximilian University, Munich, Germany.
Kami PekayvazMedizinische Klinik und Poliklinik I, University Hospital, Ludwig-Maximilian University, Munich, Germany.ORCID 0000-0003-4040-650X
Stefan KääbMedizinische Klinik und Poliklinik I, University Hospital, Ludwig-Maximilian University, Munich, Germany.ORCID 0000-0001-8824-3581
Florian GaertnerMedizinische Klinik und Poliklinik I, University Hospital, Ludwig-Maximilian University, Munich, Germany.ORCID 0000-0001-6120-3723
Konstantin StarkMedizinische Klinik und Poliklinik I, University Hospital, Ludwig-Maximilian University, Munich, Germany.
Thomas BrockerInstitute for Immunology, Biomedical Center, Medical Faculty, Ludwig-Maximilian University, Munich, Planegg-Martinsried, Germany.ORCID 0000-0001-7060-5433
Steffen MassbergMedizinische Klinik und Poliklinik I, University Hospital, Ludwig-Maximilian University, Munich, Germany.
Leo NicolaiMedizinische Klinik und Poliklinik I, University Hospital, Ludwig-Maximilian University, Munich, Germany.ORCID 0000-0003-0776-5885
German Centre for Cardiovascular Research · DELudwig-Maximilians-Universität München · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Impairment of vascular integrity is a hallmark of inflammatory diseases. We recently reported that single immune-responsive platelets migrate and reposition themselves to sites of vascular injury to prevent bleeding. However, it remains unclear how single platelets preserve vascular integrity once encountering endothelial breaches. Here we demonstrate by intravital microscopy combined with genetic mouse models that procoagulant activation (PA) of single platelets and subsequent recruitment of the coagulation cascade are crucial for the prevention of inflammatory bleeding. Using a novel lactadherin-based compound, we detect phosphatidylserine (PS)-positive procoagulant platelets in the inflamed vasculature. We identify exposed collagen as the central trigger arresting platelets and initiating subsequent PA in a CypD- and TMEM16F-dependent manner both in vivo and in vitro. Platelet PA promotes binding of the prothrombinase complex to the platelet membrane, greatly enhancing thrombin activity and resulting in fibrin formation. PA of migrating platelets is initiated by costimulation via integrin αIIbβ3 (GPIIBIIIA)/Gα13-mediated outside-in signaling and glycoprotein VI signaling, leading to an above-threshold intracellular calcium release. This effectively targets the coagulation cascade to breaches of vascular integrity identified by patrolling platelets. Platelet-specific genetic loss of either CypD or TMEM16F as well as combined blockade of platelet GPIIBIIIA and glycoprotein VI reduce platelet PA in vivo and aggravate pulmonary inflammatory hemorrhage. Our findings illustrate a novel role of procoagulant platelets in the prevention of inflammatory bleeding and provide evidence that PA of patrolling platelet sentinels effectively targets and confines activation of coagulation to breaches of vascular integrity.

Indexed as

Blood PlateletsPlatelet Membrane GlycoproteinsAnimalsHemorrhageMicePlatelet ActivationPlatelet Glycoprotein GPIIb-IIIa ComplexPlatelet Glycoprotein GPIIb-IIIa ComplexPlatelet Membrane Glycoproteins

Identifiers

PMID35472164
PMCPMC9283965
OpenAlexW4224983775

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.